Global Regulatory in the UK

We bring together regulatory and industry specialists from across sectors alongside cross-cutting experience in areas such as competition law and government affairs. That means that we can see the connections, the synergies, the anomalies — and the opportunities.

There’s a reason why Chambers UK (2021) recognized us as "a brilliant regulatory firm." We are specialists; we have a deep understanding of the sectors we work in, and a deep understanding of how governments, legislators and regulators operate, in principle and in practice. That means that we can understand, interpret, and translate business needs and policy objectives, providing you with the intelligence you need to make business-critical decisions and delivering effective engagement with decision-makers in their language.

Our 100+ regulatory lawyers and advisors in the UK work closely with our industry sector groups and other practice areas, and our regulatory colleagues around the world, to provide holistic strategies for the most challenging issues, from pulling off a key investment in a heavily regulated and politically sensitive industry to shaping the policy environment for an innovative technology or defending your reputation and licence to operate in the face of regulatory or political challenge.

To establish, grow and defend your business in a fast-changing world where regulation and government intervention are critical to competitive success and long-term sustainability, you need advisors who know more than the law. You need advisors who know where you are going and can help you navigate the complexities and sensitivities of the regulatory, policy and political environment on your journey.

Let’s go together.

Representative experience

Helping Uber to regain its licence to operate in London – twice – and to reform its governance model, systems and policies to provide a foundation for sustainable growth.

Advising Salesforce on issues relating to the GDPR and ongoing compliance, privacy and data security advice relating to key transactions, and support for its controller and processor BCR implementation.

Advising The Met Office in its £1.2bn procurement of the first ever UK contract for supercomputing capability "as a service."

Advising ITV on competition law, regulatory and policy aspects of its ground-breaking "Britbox" joint venture with the BBC and other broadcasters.

Advising Goldman Sachs on the legal and regulatory issues involved in setting up Marcus, a new retail savings bank.

Advising a major aerospace and defense company on all aspects on its compliance with UK export controls and customs and self-disclosure obligations to the UK regulators.

Advising a leading global e-money issuer on the development of payment initiation and account information services and obtaining authorisation from the FCA and Central Bank of Ireland.

Advising the City of London Corporation on both "no deal" issues and the future EU/UK relationship, including attending and preparing for Parliamentary committees hearings and briefings.

Securing a victory for Equifax in connection with a purported representative action, the largest in a privacy case in England and the first in respect of a data breach, brought in the English High Court.

Navigating a U.S. biotech innovator through a hostile UK government and parliamentary environment to secure a deal giving UK patients access to its unique life-changing treatments.

Chairing the City’s working group to develop policy proposals, including the views of the whole sector and their trade bodies, in relation to the loss of passporting.

Supporting Curve in dealing with the FCA suspension without notice of Wirecard’s permissions and the consequential rapid migration of customers and accounts to be serviced under Curve's own e-money licence.

Providing strategic intelligence to a US investor on political and policy risks relevant to a potential UK acquisition in the energy sector, and how to mitigate those risks.

Antitrust and foreign direct investment counsel to AmerisourceBergen Corporation on its US$6.47bn acquisition of Walgreens Boots Alliance, Inc.’s Alliance Healthcare wholesale distribution business in Europe.

Appointed by the UK Government to provide regulatory and legal advice on the negotiations of the UK-Australia and UK-New Zealand free trade agreements.

20 July 2023

20 July 2023 – Hogan Lovells has brought together key stakeholders from the life sciences and health care sector to discuss and tackle the issues shaping the future of the industry.

View more firm news